Wahida, Adam;Tang, Fang;Barr, Jeremy J.Rethinking phage-bacteria-eukaryotic relationships and their influence on human health..Cell Host Microbe.2021.29.5.681-688

Gurnari, Carmelo;Pagliuca, Simona;Patel, Bhumika J;Awada, Hassan;Kongkiatkamon, Sunisa;Terkawi, Laila;Zawit, Misam;Corey, Seth;Lichtin, Alan E;Carraway, Hetty E;Wahida, Adam;Visconte, Valeria;Maciejewski, Jaroslaw P.Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria..Leukemia.2021.35.8.2431-2434

Meinhardt, Anna-Lena;Munkhbaatar, Enkhtsetseg;Höckendorf, Ulrike;Dietzen, Michelle;Dechant, Marta;Anton, Martina;Jacob, Anne;Steiger, Katja;Weichert, Wilko;Brcic, Luka;McGranahan, Nicholas;Branca, Caterina;Kaufmann, Thomas;Dengler, Michael A;Jost, Philipp J.The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner..Oncogene.2022.41.9.1376-1382

Jost, P. J.;Munkhbaatar, E.;Dietzen, M.;Branca, C.;McGranahan, N..Clonal evolution in lung cancer highlights MCL-1 gains as therapeutic target in lung adenocarcinoma.J Thorac Oncol.2021.16 Suppl S.4.S704-S704

Dill, V;Wagner, C.;Keller, E.;Shoumariyeh, K.;Odinius, T.;Buschhorn, L.;Suren, C.;Hecker, J.;Herhaus, P.;Sandherr, M.;Schmidt, B.;Slotta-Huspenina, J.;Bassermann, F.;Hoeckendorf, U.;Branca, C.;Jilg, S.;Jost, P. J..RIPK3-dependent necroinflammation as a disease promoting mechanism in human myelofibrosis.Oncology Research and Treatment.2021.44 Suppl 2.161-161

Lorch, M.;Pfirrmann, M.;Fabisch, C.;Oberle, L.;Kohn, D.;Kohlbrenner, K.;Bruemmendorf, T. H.;Burchert, A.;Krause, S. W.;le Coutre, P.;Haenel, M.;Franke, G-N;Stegelmann, F.;Radsak, M.;Kunzmann, V;Jost, P. J.;Hofmann, W. -K.;Hochhaus, A.;Saussele, S..Health-related quality of life (HRQoL) in CML-patients at diagnosis compared to general population.Oncology Research and Treatment.2021.44 Suppl 2.71-72

Allmendinger, F.;Agrawal, D.;Dietzen, M.;Vosberg, S.;Munkhbaatar, E.;McGranahan, N.;Jost, P. J..Necroptosis establishes an inflammatory tumor immune microenvironment acting as tumor suppressor in lung adenocarcinoma.Ann Oncol.2021.32 Suppl 5.S945-S945

Allmendinger, F.;Agrawal, D.;Dietzen, M.;Vosberg, S.;Munkhbaatar, E.;Branca, C.;McGranahan, N.;Jost, P. J..RIPK3 downregulation in lung cancer alters the tumor immune micro-environment supporting tumor progression.Oncology Research and Treatment.2021.44 Suppl 2.51-52

Gosmann, Dario;Russelli, Lisa;Weber, Wolfgang A;Schwaiger, Markus;Krackhardt, Angela M;D'Alessandria, Calogero.Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy..EJNMMI Res.2022.12.1

Brunet, Theresa;Berutti, Riccardo;Dill, Veronika;Hecker, Judith S;Choukair, Daniela;Andres, Stephanie;Deschauer, Marcus;Diehl-Schmid, Janine;Krenn, Martin;Eckstein, Gertrud;Graf, Elisabeth;Gasser, Thomas;Strom, Tim M;Hoefele, Julia;Götze, Katharina S;Meitinger, Thomas;Wagner, Matias.Clonal Hematopoiesis as a pitfall in germline variant interpretation in the context of Mendelian disorders..Hum Mol Genet.2022